Lv, Chao <br/><br/>
A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma.  [electronic resource] 

 -  World journal of surgical oncology  Apr 2013 
 - 96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-7819 
<br/><br/><label>Standard No.: </label>10.1186/1477-7819-11-96  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Crown Ethers--administration & dosage<br/>DNA-Binding Proteins--genetics<br/>Deoxycytidine--administration & dosage<br/>Endonucleases--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Induction Chemotherapy<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Pilot Projects<br/>Prognosis<br/>Quinazolines--administration & dosage<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ribonucleoside Diphosphate Reductase<br/>Tumor Suppressor Proteins--genetics<br/>Gemcitabine